May 8, 2025 | Duane Morris LLP | Webinar
Duane Morris will hold its next Cannabis Webinar, Rescheduling vs. Decriminalization – The Movement for Cannabis Legalization and Its Impact on Today's Market, on Thursday, May 8, 2025, from 12:30 p.m. to 1:30 p.m. Eastern. REGISTER Login details will be provided in a separate communication after registration. About the Program In April 2024, the U.S. Drug Enforcement Administration recommended that cannabis be rescheduled to a Schedule III substance following an earlier recommendation from the Department of Health and Human Services. So where do the prospects of rescheduling and the industry at large stand one year later? Join us for a panel discussion with our guest, journalist filmmaker Michele Mitchell, who will examine the history of the cannabis movement, its impact on the current state of the cannabis market, and whether rescheduling or decriminalization would have the most beneficial impact for cannabis as this nascent industry continues to grow. Presenters Michele Mitchell, Award-Winning Journalist and Filmmaker Michael D. Schwamm, Partner and New York Cannabis Lead, Duane Morris LLP Tracy Gallegos, Partner and Cannabis Industry Group Team Lead, Duane Morris LLP About the Duane Morris Cannabis Industry Group Duane Morris attorneys in offices throughout the U.S. and internationally have extensive experience with the wide array of issues attendant to legal cannabis business activities. In addition to advising participants in the medical and adult-use cannabis and hemp/CBD industries, as the industry has grown, Duane Morris attorneys experienced in cannabis-related issues frequently advise clients in other sectors whose businesses intersect with the expanding regulated cannabis sector.
Duane Morris will hold its next Cannabis Webinar, Rescheduling vs. Decriminalization – The Movement for Cannabis Legalization and Its Impact on Today's Market, on Thursday, May 8, 2025, from 12:30 p.m. to 1:30 p.m. Eastern.
REGISTER
Login details will be provided in a separate communication after registration.
In April 2024, the U.S. Drug Enforcement Administration recommended that cannabis be rescheduled to a Schedule III substance following an earlier recommendation from the Department of Health and Human Services. So where do the prospects of rescheduling and the industry at large stand one year later?
Join us for a panel discussion with our guest, journalist filmmaker Michele Mitchell, who will examine the history of the cannabis movement, its impact on the current state of the cannabis market, and whether rescheduling or decriminalization would have the most beneficial impact for cannabis as this nascent industry continues to grow.
Michele Mitchell, Award-Winning Journalist and Filmmaker
Michael D. Schwamm, Partner and New York Cannabis Lead, Duane Morris LLP
Tracy Gallegos, Partner and Cannabis Industry Group Team Lead, Duane Morris LLP
Duane Morris attorneys in offices throughout the U.S. and internationally have extensive experience with the wide array of issues attendant to legal cannabis business activities. In addition to advising participants in the medical and adult-use cannabis and hemp/CBD industries, as the industry has grown, Duane Morris attorneys experienced in cannabis-related issues frequently advise clients in other sectors whose businesses intersect with the expanding regulated cannabis sector.
